COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysis
By Long-Quan Li, Tian Huang, Yong-qing Wang, Zheng-ping Wang, Yuan Liang, Tao-Bi Huang, Huiyun Zhang, Weiming Sun, Yuping Wang. Journal of Medical Virology, 2020
1,223 citations recorded by the source corpus.
The aim of this study was to analyze the clinical data, discharge rate, and fatality rate of COVID‐19 patients for clinical help. The clinical data of COVID‐19 patients from December 2019 to February 2020 were retrieved from four databases. We statistically analyzed the clinical symptoms and laboratory results of COVID‐19 patients and explained the discharge rate and fatality rate with a single‐arm meta‐analysis. The available data of 1994 patients in 10 literatures were included in our study. The main clinical symptoms of COVID‐19 patients were fever (88.5%), cough (68.6%), myalgia or fatigue (35.8%), expectoration (28.2%), and dyspnea (21.9%). Minor symptoms include headache or dizziness (12.1%), diarrhea (4.8%), nausea and vomiting (3.9%). The results of the laboratory showed that the lymphocytopenia (64.5%), increase of C‐reactive protein (44.3%), increase of lactic dehydrogenase (28.3%), and leukocytopenia (29.4%) were more common. The results of single‐arm meta‐analysis showed that the male took a larger percentage in the gender distribution of COVID‐19 patients 60% (95% CI [0.54, 0.65]), the discharge rate of COVID‐19 patients was 52% (95% CI [0.34,0.70]), and the fatality rate was 5% (95% CI [0.01,0.11]).
Subfields: Critical Care and Intensive Care Medicine, Infectious Diseases, Oncology
View Paper: https://www.semanticscholar.org/paper/5340a82ead2237f92c3868569bebcd979a0d67e6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Y. Goërtz
- M. Spruit
- Maarten van Herck
- J. Delbressine
- D. Janssen
- K. Huet
- T. Maddox
- Y. Van Laethem
Citations in the corpus
- Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study (2021, background): “34 35 choice of control group We selected a matched control group from the general population of England, allowing estimation of the excess post-covid morbidity after severe covid-19 disease.”
- Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019 (2020, background): “was mainly associated with fever, cough, dyspnea, and fatigue [8-12].”
- Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? (2020, background): “Scientists (with a background in rehabilitation sciences, psychology, sociology and pulmonology), methodologists, healthcare professionals (elderly care specialist, pulmonologists) and COVID-19 patients from the two Facebook groups were closely involved in putting together the list of 29 symptoms th”